statistiche ricercatore

Continente	#
NA - Nord America	682
AS - Asia	236
EU - Europa	149
SA - Sud America	133
Continente sconosciuto - Info sul continente non disponibili	23
AF - Africa	7
OC - Oceania	1
Totale	1.231

Nazione	#
US - Stati Uniti d'America	657
BR - Brasile	123
SG - Singapore	94
IT - Italia	60
CN - Cina	47
VN - Vietnam	32
DE - Germania	18
GB - Regno Unito	12
HK - Hong Kong	12
FR - Francia	11
FI - Finlandia	10
BD - Bangladesh	9
CA - Canada	8
IQ - Iraq	7
ES - Italia	6
JP - Giappone	6
MX - Messico	6
RU - Federazione Russa	5
CZ - Repubblica Ceca	4
IN - India	4
NL - Olanda	4
PK - Pakistan	4
AE - Emirati Arabi Uniti	3
AR - Argentina	3
BE - Belgio	3
EC - Ecuador	3
PL - Polonia	3
SE - Svezia	3
TR - Turchia	3
AZ - Azerbaigian	2
CW - ???statistics.table.value.countryCode.CW???	2
DO - Repubblica Dominicana	2
EG - Egitto	2
JM - Giamaica	2
LB - Libano	2
LT - Lituania	2
UA - Ucraina	2
ZA - Sudafrica	2
AU - Australia	1
BZ - Belize	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
DK - Danimarca	1
GP - Guadalupe	1
IE - Irlanda	1
IL - Israele	1
JO - Giordania	1
KH - Cambogia	1
KN - Saint Kitts e Nevis	1
KZ - Kazakistan	1
LC - Santa Lucia	1
MA - Marocco	1
MD - Moldavia	1
MK - Macedonia	1
MT - Malta	1
MY - Malesia	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PS - Palestinian Territory	1
RS - Serbia	1
SA - Arabia Saudita	1
SN - Senegal	1
TL - Timor Orientale	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
ZM - Zambia	1
Totale	1.211

Nome	#
Efficacy and safety of B/F/TAF in naïve people with HIV: real life data from the SHiNeSHiC research group	274
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity	165
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients	156
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study	130
Living with HIV and Getting Vaccinated: A Narrative Review	118
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort	110
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS)	106
Bictegravir/emtricitabine/tenofovir alafenamide in people with HIV aged ≥50: low discontinuation rates and favorable metabolic outcomes over 36 months	52
Present and future of HIV pre-exposure prophylaxis: a narrative review	48
Exploring the impact of Cabotegravir‐Rilpivirine long‐acting on weight gain, body composition and quality of life in adults living with HIV	39
Risk of autochthonous human schistosomiasis transmission in Italy	33
Totale	1.231

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	8	0	0	0	0	0	0	0	0	0	0	4	4
2022/2023	15	2	2	0	1	1	2	0	5	0	1	1	0
2023/2024	32	0	1	1	2	5	12	0	3	0	0	1	7
2024/2025	248	6	1	8	7	8	9	19	57	84	28	12	9
2025/2026	728	28	85	282	64	52	26	55	26	36	35	17	22
2026/2027	200	16	50	53	81	0	0	0	0	0	0	0	0
Totale													1.231